title: Market assessment of tuberculosis diagnostics in India in 2013.
abstract: BACKGROUND
  India represents a significant potential market for new tests. We assessed India's market for tuberculosis (TB) diagnostics in 2013.
  
  
  METHODS
  Test volumes and unit costs were assessed for tuberculin tests, interferon-gamma release assays, sputum smear microscopy, serology, culture, speciation testing, nucleic-acid amplification tests (i.e., in-house polymerase chain reaction, Xpert(®) MTB/RIF, line-probe assays) and drug susceptibility testing. Data from the public sector were collected from the Revised National TB Control Programme reports. Private sector data were collected through a survey of private laboratories and practitioners. Data were also collected from manufacturers.
  
  
  RESULTS
  In 2013, India's public sector performed 19.2 million tests, with a market value of US$22.9 million. The private sector performed 13.6 million tests, with a market value of US$60.4 million when prices charged to the patient were applied. The overall market was US$70.8 million when unit costs from the ingredient approach were used for the 32.8 million TB tests performed in the entire country. Smear microscopy was the most common test performed, accounting for 25% of the overall market value.
  
  
  CONCLUSIONS
  India's estimated market value for TB diagnostics in 2013 was US$70.8 million. These data should be of relevance to test developers, donors and implementers.
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: P
authors.initials: P
authors.lastname: Maheshwari
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: K
authors.initials: K
authors.lastname: Chauhan
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: R
authors.initials: R
authors.lastname: Kadam
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: A
authors.initials: A
authors.lastname: Pujani
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: M
authors.initials: M
authors.lastname: Kaur
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: M
authors.initials: M
authors.lastname: Chitalia
authors.affiliation: Clinton Health Access Initiative [CHAI], New Delhi, India.
authors.forename: H
authors.initials: H
authors.lastname: Dabas
authors.affiliation: Foundation for Innovative New Diagnostics [FIND], Geneva, Switzerland.
authors.forename: M D
authors.initials: MD
authors.lastname: Perkins
authors.affiliation: Foundation for Innovative New Diagnostics [FIND], Geneva, Switzerland.
authors.forename: C C
authors.initials: CC
authors.lastname: Boehme
authors.affiliation: Foundation for Innovative New Diagnostics [FIND], Geneva, Switzerland.
authors.forename: C M
authors.initials: CM
authors.lastname: Denkinger
authors.affiliation: Foundation for Innovative New Diagnostics [FIND], Geneva, Switzerland.
authors.forename: N
authors.initials: N
authors.lastname: Raizada
authors.affiliation: UNITAID, Geneva, Switzerland.
authors.forename: J
authors.initials: J
authors.lastname: Ginnard
authors.affiliation: Independent consultant, currently consulting for FIND and UNITAID, Philadelphia, Pennsylvania, USA.
authors.forename: C
authors.initials: C
authors.lastname: Jefferson
authors.affiliation: Independent consultant, Zurich, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Pantoja
authors.affiliation: Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
authors.forename: S
authors.initials: S
authors.lastname: Rupert
authors.affiliation: McGill International TB Centre, Montreal, Quebec, Canada.
authors.forename: S V
authors.initials: SV
authors.lastname: Kik
authors.affiliation: McGill International TB Centre, Montreal, Quebec, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Cohen
authors.affiliation: McGill International TB Centre, Montreal, Quebec, Canada.
authors.forename: P
authors.initials: P
authors.lastname: Chedore
authors.affiliation: McGill International TB Centre, Montreal, Quebec, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Satyanarayana
authors.affiliation: McGill Global Health Programs, Department of Epidemiology & Biostatistics, McGill International TB Centre, 1020 Pine Ave West, Montreal, QC, Canada H3A 1A2. madhukar.pai@mcgill.ca.
authors.forename: M
authors.initials: M
authors.lastname: Pai
mesh_terms: D006801:Humans; D007194:India; D059425:Interferon-gamma Release Tests / Q000191:economics; D008853:Microscopy / Q000191:economics; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D021141:Nucleic Acid Amplification Techniques / Q000191:economics; D016133:Polymerase Chain Reaction / Q000191:economics; D017149:Private Sector / Q000191:economics; D017150:Public Sector / Q000191:economics; D012680:Sensitivity and Specificity; D013183:Sputum / Q000382:microbiology; D014374:Tuberculin Test / Q000191:economics*; D014376:Tuberculosis / Q000175:diagnosis* / Q000191:economics*